Protara Therapeutics (TARA) Short-Term Debt repayments (2020)
Protara Therapeutics (TARA) recorded quarterly Short-Term Debt repayments of $371223.0 in Q4 2020, down 33.26% quarter-over-quarter from $556190.0 in Q3 2020.
Protara Therapeutics (TARA) Short-Term Debt repayments (2020) Analysis & Trends
Protara Therapeutics' Short-Term Debt repayments history runs 1 years deep, the most recent figure standing at $371223.0 for Q4 2020.
- In Q4 2020, Short-Term Debt repayments changed N/A year-over-year to $371223.0; the TTM figure through Dec 2020 stood at $1.7 million (changed N/A YoY), while the FY2020 annual figure was $1.7 million, changed N/A from the prior year.
- Short-Term Debt repayments was $371223.0 for Q4 2020 at Protara Therapeutics, down from $556190.0 in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $556190.0 in Q3 2020 to a low of $370793.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 102,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -482,347.21 |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 371,223.00 |
| Dec 31, 2020 | 371,223.00 |
| Sep 30, 2020 | 556,190.00 |
| Sep 30, 2020 | 556,190.00 |
| Jun 30, 2020 | 370,794.00 |
| Jun 30, 2020 | 370,794.00 |
| Mar 31, 2020 | 370,793.00 |
| Mar 31, 2020 | 370,793.00 |